Here’s yet another study suggesting persistent symptoms in kids.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle...
More than willing to provide a list of studies demonstrating viral persistence as well.
4,473 karma · joined January 1, 2022
Here’s yet another study suggesting persistent symptoms in kids.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle...
More than willing to provide a list of studies demonstrating viral persistence as well.
Before dismissing long COVID, it’s worth understanding what viruses are capable of.
This report has led to a lot of minimization and misinterpretation especially from certain bad faith actors. Some claim the number is “stable” year over year, suggesting long COVID isn’t a big deal, overlooking that this study uses a completely new sample each year, not the same children.
we now have novel technology being used like PET scanning, T cell biosensors, and single molecule ultrasensitive assays.
Antigen/superantigen persistence is shared and may be treated with extended courses of antivirals, monoclonal antibodies, immune modulators, and even trying checkpoint inhibitors to reverse T cell exhaustion.
the textbook is being rewritten and a key publication on how to treat at least Long COVID based on what I mentioned above will come out next week. NIH will launch their trials very soon likely announcing in March.
Another publication this week showed 4% of children developed Long COVID based on EHR data.
https://academic.oup.com/cid/advance-article/doi/10.1093/cid...
i.e. https://publications.aap.org/pediatrics/article/153/3/e20230... or https://www.nih.gov/news-events/news-releases/nih-funded-stu...
Note: I work on NIH efforts to cure Long COVID called RECOVER, RECOVER-TLC, and help non-profits dedicated towards viral persistence/immune dysfunction hypotheses.
It might sound unconventional, but what if taxi drivers, through constant exposure to small amounts of pathogens from travelers worldwide, experience enough immune imprinting to help prevent diseases like Alzheimer’s?
There’s an intriguing study suggesting that one type of Alzheimer’s might be linked to a chronic gut infection that eventually makes its way to the brain.
https://news.asu.edu/20241219-health-and-medicine-surprising...
We are likely on the verge of a scientific revolution that will redefine viruses as key drivers behind some of the most devastating diseases known to humanity.
there is a lot of hope and upcoming RCTs:
https://fnih.org/our-programs/accelerating-covid-19-therapeu...
here are proposed mechanisms by some of the leading researchers in this field:
https://www.sciencedirect.com/science/article/pii/S009286742...
New vaccines in development aim to include multiple proteins and improved delivery methods, which could lead to longer-lasting immunity. For now, hybrid immunity (infection plus vaccination) offers broader protection, while vaccines safely boost antibody levels without the risks of infection.
We are heavily undercounting until we can definitively link it. That requires families to consent to an autopsy and for biomarkers to be finalized and used to confirm.
Researchers are pretty close to that nowadays though with micro clots, viral rna persistence assays, and even pathology studies which are all showing results this year and will be for years to come.
This community oriented approach really provides enough transparency so the community can hold companies and infringers to a higher standard.
I work on one of the biggest registries and this is a huge problem for us and we are thinking of adopting this approach. Any reasons we shouldn’t?
I think people need to separate the dmca process and the ledger of dmca requests to separate criticism points.
genetic predisposition (immune/HLA genes working or not), infections (potential for antigen persistence), diet, environmental factors, stress, etc all also contribute heavily.
https://www.nature.com/articles/s41531-024-00716-z
https://www.nature.com/articles/d41586-024-00470-5
https://www.science.org/content/article/long-covid-trials-ai...
https://videocast.nih.gov/watch=54970
https://www.nature.com/articles/d41586-024-00871-6
https://www.nature.com/articles/d41586-024-01274-3
https://www.fda.gov/drugs/news-events-human-drugs/fda-approv...
Immunotherapy is entering the golden age and we're about to find out what and what doesn't work.
Of course variability will differ, that’s why they invest to much into improving the technology and ml algorithms to make up for the difference to personalize the data.
The watch could encourage you to go to a doctor and the doctor can use a more accurate instrument to diagnose.
Many articles these last few years on ways to renew it, ways to treat dysfunction, and the common bad guys we really need to remove from our bodies as they are directly linked to currently incurable diseases like T1D, MS, Alzheimer’s, Parkinson’s, ME/CFS, Long COVID, and more.
It seems very realistic we may cure/reverse disease course for a handful of these within the next decade at this rate. Many novel clinical trials are happening to probe at the causes and if proven, we could have new drugs quickly due to the pandemic forcing supply chains to be able to meet antigen targets.
Many boards are structured to purely benefit the company “sponsoring” and this is wrong. I’ve always looked at PSF as a means of doing it right in all regards.
I wonder how much other ecosystems can grow if they gave up the control and allowed their communities to drive progress. One of the greatest parts of python and rust is the ability to still innovate the needs of the community and not just corporate interests
While it takes time to do, it has really held me accountable to actually go learn the things I really ought to be learning rather than being stagnant.
I'm a staff PM at a big tech company and I came to realize that nobody knew this stuff, not even the people we are hiring to implement it. Therefore I decided to go out and learn it as my skillset needed a refresh (I come from the mobile dev boom)
It is a good thing that we are developing verbose pathogen panels to ensure we don’t prescribe antibiotics when we have viral infections and vice versa.
Additionally the upcoming AI discovered targeted antibiotics will be game changer to remove negative or benign pathogens while maintaining your good cultures.
The challenge is that some become friends and some become foes depending on the diversity and quantity of certain species.
Gut microbiome discoveries are going to change the way we see disease in this next decade.
> High uptake in the gut was observed in people with persistent post-COVID-19 symptoms, as was single and double-stranded SARS-CoV-2 RNA in gut lamina propria, as measured directly by ISH in a subset of participants
With modern day technology, we are now able to scan the whole body before and after a treatment. This can be applied to many diseases like Parkinson's, but largely being used in Long COVID trials today:
> The ability to quantify pathogen and immune responses across the whole body before and after a therapeutic intervention could provide unparalleled information on infections that primarily persist in specific tissues outside the systemic circulation
Finally, we really are entering a renaissance of being able to see our immune system in action for the first time. This will hopefully bring a cure to many diseases that are now thought to be driven by immune dysfunction / viral persistence / autoimmunity / etc.
> Nonetheless, we are just entering a renaissance of specific noninvasive nuclear imaging developments to determine immune responses to pathogens and malignancies. For these to be realized, significant resources must be provided to develop, implement and improve these emerging noninvasive technologies and facilitate their implementation into clinical trial infrastructure.
https://www.nature.com/articles/s41590-024-01948-0 (may be paywalled, but is a great article)
Beyond the nuclear imaging technologies, new tools like single-cell RNA sequencing, CRISPR screens, 5′-VDJ repertoire analysis, spatial transcriptomics, dual RNA sequencing and metagenomic sequencing, etc will help in unraveling the complexities of these complex diseases.
Bonus: Here's a video of a friend who did this experimental imaging for Long COVID:
https://www.youtube.com/watch?v=QPwXRZFhGOM
Hippocrates said all disease begins in it, so maybe we should've listened.
Among the 3,860 participants, 20% of school-age children and 14% of adolescents met the criteria for long COVID.
Common symptoms included headaches, memory issues, and fatigue.
This study underscores the need for age-specific research to better understand and treat long COVID in youth.
Future research will focus on children under 5.
https://www.yomiuri.co.jp/medical/20240821-OYT1T50067/
The US has a scary picture too with ~11% of adults affected today:
https://www.hhs.gov/sites/default/files/long-covid-update-20...
https://www.fda.gov/media/133864/download#:~:text=Right%20to....
The FDA is a joke. I mean that in the kindest way possible as someone with long covid waiting for the FDA to allow me access to previous covid therapeutics that show promise in this disease.
The more important parts of their programs are the omics and tissue biopsy programs.
May they hopefully turn the ship…